0000950170-24-005513.txt : 20240118 0000950170-24-005513.hdr.sgml : 20240118 20240118181845 ACCESSION NUMBER: 0000950170-24-005513 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240116 FILED AS OF DATE: 20240118 DATE AS OF CHANGE: 20240118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adjuvant Global Health Technology Fund, L.P. CENTRAL INDEX KEY: 0001783165 ORGANIZATION NAME: STATE OF INCORPORATION: E9 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41331 FILM NUMBER: 24543198 BUSINESS ADDRESS: STREET 1: C/O ADJUVANT CAPITAL, L.P. STREET 2: 501 FIFTH AVENUE, SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 917-334-0724 MAIL ADDRESS: STREET 1: C/O ADJUVANT CAPITAL, L.P. STREET 2: 501 FIFTH AVENUE, SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adjuvant Global Health Technology Fund DE, L.P. CENTRAL INDEX KEY: 0001799812 ORGANIZATION NAME: STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41331 FILM NUMBER: 24543197 BUSINESS ADDRESS: STREET 1: C/O ADJUVANT CAPITAL, L.P. STREET 2: 501 FIFTH AVENUE, SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 917-334-0724 MAIL ADDRESS: STREET 1: C/O ADJUVANT CAPITAL, L.P. STREET 2: 501 FIFTH AVENUE, SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adjuvant Capital GP, L.P. CENTRAL INDEX KEY: 0001935100 ORGANIZATION NAME: STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41331 FILM NUMBER: 24543196 BUSINESS ADDRESS: STREET 1: 501 FIFTH AVENUE STREET 2: SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 917-334-0724 MAIL ADDRESS: STREET 1: 501 FIFTH AVENUE STREET 2: SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Adjuvant Capital Management, LLC CENTRAL INDEX KEY: 0001935084 ORGANIZATION NAME: STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41331 FILM NUMBER: 24543195 BUSINESS ADDRESS: STREET 1: 501 FIFTH AVENUE STREET 2: SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 917-334-0724 MAIL ADDRESS: STREET 1: 501 FIFTH AVENUE STREET 2: SUITE 1404 CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AN2 Therapeutics, Inc. CENTRAL INDEX KEY: 0001880438 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 820606654 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1800 EL CAMINO REAL, SUITE D CITY: MENLO PARK STATE: CA ZIP: 94027 BUSINESS PHONE: (650) 331-9090 MAIL ADDRESS: STREET 1: 1800 EL CAMINO REAL, SUITE D CITY: MENLO PARK STATE: CA ZIP: 94027 4 1 ownership.xml 4 X0508 4 2024-01-16 true 0001880438 AN2 Therapeutics, Inc. ANTX 0001783165 Adjuvant Global Health Technology Fund, L.P. C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017 false false true false 0001799812 Adjuvant Global Health Technology Fund DE, L.P. C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017 false false true false 0001935100 Adjuvant Capital GP, L.P. C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017 false false true false 0001935084 Adjuvant Capital Management, LLC C/O ADJUVANT CAPITAL, L.P. 501 FIFTH AVENUE, SUITE 1404 NEW YORK NY 10017 false false true false false Common Stock 2024-01-16 4 S false 84093 19.65 D 1995958 D Common Stock 2024-01-16 4 S false 15907 19.65 D 377542 I By Adjuvant Global Health Technology Fund DE, L.P. Shares held directly by Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund"). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities. Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE"). The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities. Adjuvant Global Health Technology Fund, L.P., By: Adjuvant Capital GP, L.P., its sole general partner, By: Adjuvant Capital Management, L.L.C., its sole general partner, By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz 2024-01-18 Adjuvant Global Health Technology Fund DE, L.P., By: Adjuvant Capital GP, L.P., its sole general partner, By: Adjuvant Capital Management, L.L.C., its sole general partner, By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz 2024-01-18 Adjuvant Capital GP, L.P., By: Adjuvant Capital Management, L.L.C., its sole general partner, By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz 2024-01-18 Adjuvant Capital Management, L.L.C., By: Kabeer Aziz, Secretary, /s/ Kabeer Aziz 2024-01-18